-
With the elections over, the majority of the country has spoken. Like it or not, healthcare is going to irrevocably change in the United States. There are challenges to say the least, but there are also lots of opportunities for the U.S. healthcare industry as we start down this path.
-
Ninety percent of informed consent disputes involve disagreements about who said what and when, according to an analysis of 481 malpractice claims and patient complaints from Australia involving allegations of deficiencies in the process of obtaining informed consent.
-
The Centers for Medicare & Medicaid Services (CMS) has released the final rule for ambulatory surgery center (ASC) and hospital outpatient department (HOPD) payments in 2013.
-
Like many outpatient surgery facilities, you face drug shortages. You might have felt relief that youve been able to rely on compounding pharmacies to obtain the drugs you need in the single-use dosage you need until you learned about a nationwide meningitis outbreak from contaminated steroid medications originating at a Massachusetts compounding facility.
-
With outpatient surgery becoming increasingly complex, in terms of technology and patients, there is a growing trend toward requiring nurses to have their bachelor's of science in nursing (BSN) degree.
-
The authors concluded that interruption of warfarin therapy in non-valvular atrial fibrillation patients increased the short-term risk of death or thromboembolism, especially during the first 90 days of treatment interruption.
-
The ECG shown above was obtained from a 22-year-old man in a wheelchair. How would you interpret the tracing? Can you think of a condition that might account for this clinical scenario?
-
Biomarkers in the cerebrospinal fluid open the possibility of diagnosing early or even presymptomatic cases of Alzheimer's disease, thereby expanding the potential window for therapy.
-
Dementia and benzodiazepines; effectiveness of omega-3 fatty acid and Ginkgo biloba supplements; and FDA actions.
-
Celiac disease (CD), also known as gluten-sensitive enteropathy as well as two older and no longer recommended terms,3 nontropical sprue and celiac sprue, is a chronic immune-mediated disorder induced by dietary gluten in genetically susceptible individuals. In CD patients, the ingestion of gluten results in the development of small intestinal mucosal villous atrophy with crypt hyperplasia and mucosal inflammation. Patients may be asymptomatic or may manifest classic malabsorptive symptoms of abdominal pain, bloating, weight loss, diarrhea, and steatorrhea. They also may present along a spectrum with more subtle gastrointestinal and/or extraintestinal symptoms and signs of the disease; virtually every body system can be affected.